Islam N, Ferro V
En la tabla 2 se resumen las indicaciones, la posologa, el uso en insuficiencia renal y las condiciones de visado de los arGLP-1 de accin corta 6,7
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest Statements Conflict of interest Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma
Cooper BM, Iegre J, ODonovan DH, Halvarsson M, Spring DR (2021) Peptides as a platform for targeted therapeutics for cancer: peptidedrug conjugates (PDCs)
Administer Wegovy injections as instructed, rotating injection sites